|
LPAR2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.021300E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.443800E-04 |
| Normal-vs-Stage2 |
7.739800E-02 |
| Normal-vs-Stage3 |
3.432200E-01 |
| Normal-vs-Stage4 |
9.636800E-01 |
| Stage1-vs-Stage2 |
1.748570E-01 |
| Stage1-vs-Stage3 |
1.203010E-01 |
| Stage1-vs-Stage4 |
9.353800E-02 |
| Stage2-vs-Stage3 |
6.385000E-01 |
| Stage2-vs-Stage4 |
1.813430E-01 |
| Stage3-vs-Stage4 |
5.435200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.201500E-04 |
| Normal-vs-AfricanAmerican |
2.586500E-02 |
| Normal-vs-Asian |
3.590000E-01 |
| Caucasian-vs-AfricanAmerican |
3.562200E-01 |
| Caucasian-vs-Asian |
6.790800E-01 |
| AfricanAmerican-vs-Asian |
5.922200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.738550E-03 |
| Normal-vs-Female |
2.264000E-03 |
| Male-vs-Female |
4.907800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.037900E-02 |
| Normal-vs-Extreme_Weight |
1.382230E-02 |
| Normal-vs-Obese |
1.025840E-02 |
| Normal-vs-Extreme_Obese |
1.505020E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.921400E-01 |
| Normal_Weight-vs-Obese |
7.751400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.307800E-01 |
| Extreme_Weight-vs-Obese |
6.021800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.370400E-01 |
| Obese-vs-Extreme_Obese |
6.221600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.604560E-01 |
| Normal-vs-Age(41-60Yrs) |
1.103650E-03 |
| Normal-vs-Age(61-80Yrs) |
9.842200E-04 |
| Normal-vs-Age(81-100Yrs) |
2.555600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.368000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.581800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.392200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.271600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.182200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.784800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.357200E-04 |
| Normal-VS-Type2 PRCC |
4.143600E-01 |
| Normal-VS-KIRP CIMP |
8.661600E-01 |
| Normal-VS-Unclassified PRCC |
5.139900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.060140E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.959800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.156800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.024000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.580200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.817900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.018000E-01 |
| Normal-vs-N1 |
1.261810E-01 |
| Normal-vs-N2 |
4.894600E-01 |
| N0-vs-N1 |
4.350000E-01 |
| N0-vs-N2 |
3.483000E-01 |
| N1-vs-N2 |
3.205600E-01 |
|
|
